Abstract

With the rapid progress of genetic engineering and gene therapy, the World Anti-Doping Agency has been alerted to gene doping and prohibited its use in sports. However, there is no standard method available yet for the detection of transgenes delivered by recombinant adenoviral (rAdV) vectors. Here, we aim to develop a detection method for transgenes delivered by rAdV vectors in a mouse model that mimics gene doping. These rAdV vectors containing the mCherry gene was delivered in mice through intravenous injection or local muscular injection. After five days, stool and whole blood samples were collected, and total DNA was extracted. As additional experiments, whole blood was also collected from the mouse tail tip until 15 days from injection of the rAdv vector. Transgene fragments from different DNA samples were analyzed using semi-quantitative PCR (sqPCR), quantitative PCR (qPCR), and droplet digital PCR (ddPCR). In the results, transgene fragments could be directly detected from blood cell fraction DNA, plasma cell-free DNA, and stool DNA by qPCR and ddPCR, depending on specimen type and injection methods. We observed that a combination of blood cell fraction DNA and ddPCR was more sensitive than other combinations used in this model. These results could accelerate the development of detection methods for gene doping.

Highlights

  • Doping is an act of raising competitive abilities to achieve success by using substances or methods prohibited in sports [1]

  • We focused on recombinant adenoviral (rAdV) vectors, since rAdV vectors are the most commonly used in clinical trials [15] (Table 1), and are used as prescription drugs [12,13,14]

  • We tried to develop a detection method for transgenes delivered by rAdV vectors in a gene delivery mouse model

Read more

Summary

Introduction

Doping is an act of raising competitive abilities to achieve success by using substances or methods prohibited in sports [1]. Especially in festivals such as the Olympic Games and in world or local championships for various competitions, is considered illegal and against the spirit of the game. With the rapid progress of genetic engineering technology and gene therapy, WADA has been strongly alerted against gene doping. WADA has added “gene doping” to its prohibited list. In 2004, WADA created a panel of experts on gene doping to investigate the latest advances in the field of gene therapy, and the methods for detecting doping [3].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.